Researchers demonstrated that sermorelin, a synthetic growth hormone-releasing peptide, can penetrate through human skin (epidermis) in laboratory conditions. This finding raised the possibility that transdermal delivery could be a viable route for administering this peptide, potentially avoiding the need for injections.
Lodén, M; Faijerson, Y